|
15
|
Sigal Levy, Nili Guttmann-Beck and Dorit Shweiki.
Clustering Alzheimer’s Disease Gene Expression Dataset Reveals Underlying Sexually Dimorphic and Disease Status Profiles, Journal of Alzheimer's Disease Reports, volume 5, number 1, pages 541–547, June 30, 2021.
|
|
14
|
D. Shweiki.
Contemplating on the Etiology of COVID-19 Severity and Mortality Sex Differences, Gender and the Genome, October 28, 2020.
|
|
13
|
G. Shahaf and D. Shweiki.
Nonsense-mediated mRNA decay immunity can help identify human polycistronic transcripts, PLoS One, volume 9:e91535, March 2014.
|
|
12
|
D. Shweiki, A. Ben-Yehudah, C. Redinger, Easley CAt, S. Doron and G. Schatten.
Sexually dimorphic gene expression in non-human primate ESCs analyzed stringently, Biochem Biophys Res Commun, volume 414, pages 631–634, 2011.
|
|
11
|
S. Doron and D. Shweiki.
SNP uniqueness problem: a proof-of-principle in HapMap SNPs, Hum Mutat, volume 32, pages 355-357, January 2011.
|
|
10
|
R. Gilat and D. Shweiki.
A novel function for alternative polyadenylation as a rescue pathway from NMD surveillance, Biochem Biophys Res Commun, volume 353, pages 487–492, 2007.
|
|
9
|
R. Gilat, S. Goncharov, N. Esterman and D. Shweiki.
Under-representation of PolyA/PolyT tailed ESTs in human ESTdb: an obstacle to alternative polyadenylation inference, Bioinformation, pages 220–224, October 2006.
|
|
8
|
D. Shweiki.
Earth–moon evolution: implications for the mechanism of the biological clock?, Med Hypotheses, volume 56, pages 547–551, 2001.
|
|
7
|
D. Shweiki.
The physical imperative in circadian rhythm: a cytoskeleton-related physically resettable clock mechanism hypothesis, Med Hypotheses, volume 53, pages 413–420, 1999.
|
|
6
|
D. Shweiki, M. Neeman, A. Itin and E. Keshet.
Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis, Proc Natl Acad Sci U S A, volume 92, pages 768–772, 1995.
|
|
5
|
I. Stein, M. Neeman, D. Shweiki, A. Itin and E. Keshet.
Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes, Mol Cell Biol, volume 15, number 10, pages 5363–5368, 1995.
|
|
4
|
J. Pe'er, D. Shweiki, A. Itin, I. Hemo, H. Gnessin and E. Keshet.
Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases, Lab Invest, volume 72, number 6, pages 638–645, June 1995.
|
|
3
|
S. Banai, D. Shweiki, A. Pinson, M. Chandra, G. Lazarovici and E. Keshet.
Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis, Cardiovasc Res, volume 28, pages 1176–1179, 1994.
|
|
2
|
D. Shweiki, A. Itin, G. Neufeld, H. Gitay-Goren and E. Keshet.
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis, J Clin Invest, volume 91, pages 2235–2243, 1993.
|
|
1
|
D. Shweiki, A. Itin, D. Soffer and E. Keshet.
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, volume 359, pages 843–845, 1992.
|
